PPARG and breast carcinoma: Interestingly, it has been reported that ligand-activated PPARγ can inhibit CAF-induced effects on breast cancer cell interfering with the CXCR4/stromal cell-derived factor-1 (SDF-1) α axis, which plays a crucial role in mediating breast cancer cell invasion and metastasis.